Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)

NCT07136428 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07136428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07136428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)
Lead sponsor
Duke University
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 7, 2026
Completion date
November 1, 2032
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2+ metastatic breast cancer